How VEVYE Helps Dry Eye in Neuro-Eye Patients
Part of Eyes & vision clinical trials.
This study tracks whether VEVYE®, a prescription eye drop, reduces dry eye symptoms and signs in people who have both a neuro-ophthalmic condition (a nerve or brain issue affecting the eyes) and dry eye disease. You'll visit the clinic for 6 months and answer questions about your eye comfort.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with a neuro-ophthalmic condition (a neurological issue affecting your eyes)
- You have been diagnosed with dry eye disease and have an OSDI score of 23 or higher (a standardized dry-eye severity measure)
- Your doctor has determined that VEVYE is appropriate for you before the study starts
- You can attend study visits and complete questionnaires over 6 months
- You do not currently wear contact lenses (or agree to stop wearing them for the entire study)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a combination of two eye drop medications (Vevye and Flarex) to see if they work better together for treating moderate to severe dry eye. If you have persistent dry eye that hasn't improved with other treatments, this trial might help you and advance treatment options.
This study tests a new eye drop (5% VVN001) to treat dry eye disease that hasn't improved enough with artificial tears. It may help people with moderate-to-severe dry eye and low tear production.
This study tests whether a newer cyclosporine drop (Vevye) works better than a generic cyclosporine drop for people with dry eye disease. You will use one of the two drops for 8 weeks and have eye exams to see how your symptoms and eye health change.
This study tests if Vevye eye drops can improve symptoms of meibomian gland dysfunction, a condition where the tiny oil glands in your eyelids get blocked. It may help reduce dryness and discomfort.
This trial tests whether an anti-inflammatory eye drop (ciclosporin A) can help dry eyes by changing immune cells on the eye's surface. It lasts 12 weeks and may be an option for people with moderate to severe dry eye.
This study tests new eye drops for people with mild to moderate dry eye disease. It will check how well the drops work and if they are safe over time.
Hear when a new Dry Eye trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.